Bluejay Diagnostics Income Statement (2022-2023) | BJDX

Income Statement Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023
Revenue & cost
Revenue 0.05M0.25M0.14M0.09M
Cost of Revenue 0.05M0.20M0.15M0.15M0.15M
Gross Profit 0.05M
Operating items
Research & Development 0.69M0.76M1.38M1.32M1.35M1.68M
Selling, General & Administrative 1.32M1.20M1.28M0.96M1.18M1.07M
Other Operating Expenses 0.05M0.08M0.15M0.17M0.15M0.15M
Operating Expenses 2.07M2.03M2.81M2.45M2.68M2.90M
Operating Income -2.07M-1.99M-2.81M-2.45M-2.68M-2.90M
EBIT -2.07M-1.99M-2.81M-2.45M-2.68M-2.90M
Non-operating items
Other Non Operating Income 0.06M0.00M0.09M
Non Operating Income 0.05M0.05M-0.15M0.00M0.14M0.09M
Net income details
EBT -2.07M-1.99M-2.81M-2.45M-2.68M-2.90M
Profit After Tax -2.01M-1.94M-2.96M-2.39M-2.54M-2.81M
Income from Continuing Operations -2.07M-1.99M-2.81M-2.45M-2.68M-2.90M
Consolidated Net Income -2.07M-1.99M-2.81M-2.45M-2.68M-2.90M
Income towards Parent Company -2.07M-1.99M-2.81M-2.45M-2.68M-2.90M
Net Income towards Common Stockholders -2.07M-1.99M-2.81M-2.45M-2.68M-2.90M
Additional items
EPS (Basic) -0.10-2.00-2.94-2.36-2.63-22.00
EPS (Weighted Average and Diluted) -0.10-1.97-2.79-2.43-2.63-22.71
Shares Outstanding (Weighted Average) 20.14M1.01M1.01M1.01M1.02M0.13M0.14M
Shares Outstanding (Diluted Average) 20.14M1.01M1.01M1.01M1.02M0.13M0.14M
EBITDA -2.07M-1.99M-2.81M-2.45M-2.68M-2.90M